日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Salmonella choleraesuis Ketol-acid reductoisomerase (ilvC) CSB-YP691080SBF
CSB-EP691080SBF
CSB-BP691080SBF
CSB-MP691080SBF
CSB-EP691080SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis D-ribose pyranase (rbsD) CSB-YP691081SBF
CSB-EP691081SBF
CSB-BP691081SBF
CSB-MP691081SBF
CSB-EP691081SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis ATP synthase subunit c (atpE), partial CSB-YP691082SBF1
CSB-EP691082SBF1
CSB-BP691082SBF1
CSB-MP691082SBF1
CSB-EP691082SBF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Bifunctional protein GlmU (glmU) CSB-YP691083SBF
CSB-EP691083SBF
CSB-BP691083SBF
CSB-MP691083SBF
CSB-EP691083SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis DNA replication and repair protein recF (recF) CSB-YP691084SBF
CSB-EP691084SBF
CSB-BP691084SBF
CSB-MP691084SBF
CSB-EP691084SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Uncharacterized protein yicS (yicS) CSB-YP691085SBF
CSB-EP691085SBF
CSB-BP691085SBF
CSB-MP691085SBF
CSB-EP691085SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Orotate phosphoribosyltransferase (pyrE) CSB-YP691086SBF
CSB-EP691086SBF
CSB-BP691086SBF
CSB-MP691086SBF
CSB-EP691086SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Phosphopantetheine adenylyltransferase (coaD) CSB-YP691087SBF
CSB-EP691087SBF
CSB-BP691087SBF
CSB-MP691087SBF
CSB-EP691087SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis L-lactate dehydrogenase [cytochrome] (lldD) CSB-YP691088SBF
CSB-EP691088SBF
CSB-BP691088SBF
CSB-MP691088SBF
CSB-EP691088SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Glycine--tRNA ligase beta subunit (glyS), partial CSB-YP691089SBF
CSB-EP691089SBF
CSB-BP691089SBF
CSB-MP691089SBF
CSB-EP691089SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Sulfurtransferase TusA (tusA) CSB-YP691090SBF
CSB-EP691090SBF
CSB-BP691090SBF
CSB-MP691090SBF
CSB-EP691090SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Glucose-1-phosphate adenylyltransferase (glgC) CSB-YP691091SBF
CSB-EP691091SBF
CSB-BP691091SBF
CSB-MP691091SBF
CSB-EP691091SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Ferrous iron transport protein B (feoB), partial CSB-YP691092SBF
CSB-EP691092SBF
CSB-BP691092SBF
CSB-MP691092SBF
CSB-EP691092SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis 3-dehydroquinate synthase (aroB) CSB-YP691093SBF
CSB-EP691093SBF
CSB-BP691093SBF
CSB-MP691093SBF
CSB-EP691093SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis Glutathione-regulated potassium-efflux system protein KefB (kefB), partial CSB-YP691094SBF
CSB-EP691094SBF
CSB-BP691094SBF
CSB-MP691094SBF
CSB-EP691094SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis 30S ribosomal protein S12 (rpsL) CSB-YP691095SBF
CSB-EP691095SBF
CSB-BP691095SBF
CSB-MP691095SBF
CSB-EP691095SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis 50S ribosomal protein L4 (rplD) CSB-YP691096SBF
CSB-EP691096SBF
CSB-BP691096SBF
CSB-MP691096SBF
CSB-EP691096SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis 50S ribosomal protein L29 (rpmC) CSB-YP691097SBF
CSB-EP691097SBF
CSB-BP691097SBF
CSB-MP691097SBF
CSB-EP691097SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis 30S ribosomal protein S8 (rpsH) CSB-YP691098SBF
CSB-EP691098SBF
CSB-BP691098SBF
CSB-MP691098SBF
CSB-EP691098SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella choleraesuis 50S ribosomal protein L36 1 (rpmJ1) CSB-YP691099SBF
CSB-EP691099SBF
CSB-BP691099SBF
CSB-MP691099SBF
CSB-EP691099SBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×